Related Experiment Video
Updated: Jun 8, 2026
03:52
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
Optimal management of sarcopenia.
Louise A Burton1, Deepa Sumukadas
1Ageing and Health, Division of Medical Sciences, University of Dundee, Dundee, Scotland, United Kingdom.
Clinical Interventions in Aging
|September 21, 2010
Summary
Sarcopenia, the age-related loss of muscle, is driven by multiple factors. Resistance training is effective, but new pharmacological options for sarcopenia require further study.
Area of Science:
- Gerontology
- Muscle physiology
- Aging research
Background:
- Sarcopenia, characterized by loss of muscle mass, strength, and function, is a significant consequence of aging.
- The increasing elderly population necessitates effective strategies to mitigate age-related decline and disability.
- Understanding sarcopenia's mechanisms is crucial for developing interventions.
Purpose of the Study:
- To review the underlying mechanisms of sarcopenia.
- To discuss current diagnostic approaches for sarcopenia.
- To explore potential interventions for managing sarcopenia.
Main Methods:
- Literature review of sarcopenia mechanisms.
- Analysis of diagnostic criteria for sarcopenia.
- Evaluation of existing and emerging interventions for sarcopenia.
Main Results:
- Sarcopenia involves muscle mass loss, inflammation, hormonal changes, poor nutrition, and altered renin-angiotensin system.
- A lack of standardized diagnostic criteria complicates sarcopenia management.
- Pharmacological interventions show limited efficacy, though angiotensin-converting enzyme inhibitors warrant further investigation.
Conclusions:
- Resistance training is the most effective intervention for sarcopenia.
- Older adults may face barriers to strenuous exercise.
- Further research is needed for effective pharmacological treatments for sarcopenia.
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...